Versavo 100 Mg inj image 1
01 / 04

Genuine Medicines

Tracked Shipping

Plain Packaging

Order Metadata
ReferenceGH·VERSAVO1
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·VERSAVO1Anti-Cancer / Oncology Medicines

Versavo 100 Mg inj

Bevacizumab is a prescription targeted cancer medicine used to treat several cancers, including metastatic colorectal, non-small cell lung, ovarian, cervical, kidney, liver, and brain (glioblastoma) cancers. It is a monoclonal antibody that blocks VEGF, a protein that tumors use to grow new blood vessels. It is given as an infusion into a vein by trained healthcare staff, usually every two to three weeks. It must be used only under the supervision of a cancer specialist.

Order This Product

Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.

Description

Bevacizumab is a humanized monoclonal antibody that binds to vascular endothelial growth factor (VEGF), which prevents tumors from building the new blood vessels they need to grow and spread. It is usually given together with chemotherapy, and in some cases with other targeted or immune therapies, and it is prescribed for metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, ovarian, fallopian tube, and peritoneal cancer, cervical cancer, renal cell carcinoma, hepatocellular carcinoma (with atezolizumab), and recurrent glioblastoma. It is given as an intravenous infusion, with the first dose over 90 minutes and later doses over 60 and then 30 minutes if tolerated, and the dose is based on body weight (commonly 5 to 15 mg per kg every two to three weeks). Biosimilar versions are widely available and are used in the same way. Blood pressure and urine protein are checked regularly during treatment. Common side effects include high blood pressure, tiredness, nosebleeds, headache, diarrhea, mouth sores, loss of appetite, and protein in the urine. Serious but less common risks include bleeding, blood clots (including in arteries, leading to stroke or heart attack), holes in the stomach or bowel (perforation), and problems with wound healing, so it should be stopped before and after surgery, usually for at least 28 days before and until wounds heal. Severe headache, vision changes, confusion, or seizures may signal a rare brain condition (PRES) and need urgent medical care. Severe abdominal pain, coughing up blood, chest pain, or sudden weakness also needs emergency attention. It can cause heart failure and kidney problems, so heart and urine checks may be needed. Fever or signs of infection during treatment need prompt attention. It can harm an unborn baby and affect fertility in women, so effective contraception is advised during treatment and for about six months afterward, and breastfeeding should be avoided. Treatment should never be missed, changed, or stopped without the oncology team’s advice.

Specifications

Composition
Bevacizumab
Strength
100 mg
Manufacturer
Dr Reddy,s
Treatment
Cancer Medicine
Packaging Type
Vial
Packaging Size
1 Vial

How this product reaches you

  1. 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
  2. 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
  3. 3Your country's import rules apply — we help you understand them on chat.

Similar Products